April 19, 2016
April 19, 2016 - PRESSADVANTAGE -
ZofranLegal.com reports on an order given by the Honorable Judge F. Dennis Saylor IV, who is overseeing Zofran birth defect lawsuits consolidated in the Boston MDL. This new order will likely aid in simplifying the filing process for Zofran-related birth defect lawsuits. Judge Saylor noted that plaintiffs filing Zofran lawsuits will now be able to do so directly into the current MDL, to join with hundreds of other cases which have been consolidated there.
Lawsuits consolidated in the MDL were transferred by an order from the U.S. Judicial Panel on Multidistrict Litigation. As the plaintiffs involved have filed against the same defendant, and have expressed common allegations, the cases were consolidated in order to ‘fast track’ legal proceedings and conserve the time and finances of those involved. The new ruling now essentially ensures that rather than requiring plaintiffs to initially file in the federal court of their own states prior to having their cases transferred to join those in the MDL, those filing will now be able to do so directly on the MDL docket, thus greatly simplifying the filing process.
This new order is Judge Saylor’s sixth, and should greatly help future Zofran lawsuit plaintiffs as they look to file. The lawsuit numbers are expected to continue to grow in number as time goes on. Lawsuits which have been consolidated in the MDL were filed against pharmaceutical giant GlaxoSmithKline, who is the manufacturer of anti-nausea drug Zofran. Plaintiffs involved similarly allege that fetal exposure to the drug through their mothers causes unborn babies to develop serious and potentially fatal congenital birth defects. Defects which are most commonly named in the lawsuits include: clubfoot, congenital heart defects, transposition of the greater vessels, respiratory distress, kidney defects, and cleft lip and palate.
The attorneys of Monheit Law are now working to assist other women who have taken Zofran while pregnant, and who have gone on to give birth to children with defects. They want to help ensure that everyone who may have been affected will be provided with the important opportunity to explore their legal rights in the matter. These patients may be entitled to significant compensation gained through legal action. To better assist those wanting to further investigate their rights, the attorneys of Monheit Law are now offering complimentary legal consultations for qualified individuals.
To ask questions or request additional information, please contact Michael Monheit, Esq. by calling (877) 620-8411.
###
For more information about ZofranLegal.com, contact the company here:
ZofranLegal.com
Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046
Sponsored by an alliance of attorneys, ZofranLegal.com is a resource for parents, families and birth defect survivors interested in learning more about litigation surrounding the nausea drug Zofran and its link to increased risks of major birth defects.
Michael Monheit
1368 Barrowdale Road, Rydal, PA 19046
1-877-620-8411
michael@monheit.com
Visit Website
